vs
Alkermes plc.（ALKS）与Ryman Hospitality Properties, Inc.（RHP）财务数据对比。点击上方公司名可切换其他公司
Ryman Hospitality Properties, Inc.的季度营收约是Alkermes plc.的1.9倍（$737.8M vs $384.5M），Alkermes plc.净利率更高（12.8% vs 10.1%，领先2.7%），Ryman Hospitality Properties, Inc.同比增速更快（13.9% vs -10.6%），Alkermes plc.自由现金流更多（$170.0M vs $58.5M），过去两年Ryman Hospitality Properties, Inc.的营收复合增速更高（18.2% vs 4.8%）
Alkermes plc是一家全产业链布局的生物制药企业，专注于精神障碍与神经系统疾病相关药物的研发。公司1987年由迈克尔·沃尔创立，2011年9月与原Élan集团旗下的药物制剂及生产部门Elan Drug Technologies合并，总部位于都柏林，在马萨诸塞州沃尔瑟姆设有研发中心，俄亥俄州威尔明顿建有生产基地。
莱曼酒店地产是一家主营酒店、度假村、娱乐及媒体业务的企业，得名于旗下位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾为俄克拉荷马出版公司子公司时期，1983年收购WSM公司后奠定现代业务基础，同时将知名演出IP大奥普里等核心资产纳入麾下。
ALKS vs RHP — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $384.5M | $737.8M |
| 净利润 | $49.3M | $74.5M |
| 毛利率 | 88.0% | 41.4% |
| 营业利润率 | 15.1% | 19.4% |
| 净利率 | 12.8% | 10.1% |
| 营收同比 | -10.6% | 13.9% |
| 净利润同比 | -66.3% | 3.0% |
| 每股收益（稀释后） | $0.29 | $1.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $384.5M | $737.8M | ||
| Q3 25 | $394.2M | $592.5M | ||
| Q2 25 | $390.7M | $659.5M | ||
| Q1 25 | $306.5M | $587.3M | ||
| Q4 24 | $430.0M | $647.6M | ||
| Q3 24 | $378.1M | $550.0M | ||
| Q2 24 | $399.1M | $613.3M | ||
| Q1 24 | $350.4M | $528.3M |
| Q4 25 | $49.3M | $74.5M | ||
| Q3 25 | $82.8M | $34.9M | ||
| Q2 25 | $87.1M | $71.8M | ||
| Q1 25 | $22.5M | $63.0M | ||
| Q4 24 | $146.5M | $72.3M | ||
| Q3 24 | $92.4M | $59.0M | ||
| Q2 24 | $91.4M | $100.8M | ||
| Q1 24 | $36.8M | $42.8M |
| Q4 25 | 88.0% | 41.4% | ||
| Q3 25 | 86.9% | 40.9% | ||
| Q2 25 | 87.3% | 49.7% | ||
| Q1 25 | 83.9% | 44.4% | ||
| Q4 24 | 85.6% | 40.4% | ||
| Q3 24 | 83.3% | 43.1% | ||
| Q2 24 | 84.6% | 48.4% | ||
| Q1 24 | 83.3% | 41.5% |
| Q4 25 | 15.1% | 19.4% | ||
| Q3 25 | 22.6% | 15.0% | ||
| Q2 25 | 23.8% | 21.1% | ||
| Q1 25 | 4.5% | 19.8% | ||
| Q4 24 | 37.8% | 18.6% | ||
| Q3 24 | 27.7% | 19.3% | ||
| Q2 24 | 27.5% | 27.4% | ||
| Q1 24 | 12.4% | 18.2% |
| Q4 25 | 12.8% | 10.1% | ||
| Q3 25 | 21.0% | 5.9% | ||
| Q2 25 | 22.3% | 10.9% | ||
| Q1 25 | 7.3% | 10.7% | ||
| Q4 24 | 34.1% | 11.2% | ||
| Q3 24 | 24.4% | 10.7% | ||
| Q2 24 | 22.9% | 16.4% | ||
| Q1 24 | 10.5% | 8.1% |
| Q4 25 | $0.29 | $1.12 | ||
| Q3 25 | $0.49 | $0.53 | ||
| Q2 25 | $0.52 | $1.12 | ||
| Q1 25 | $0.13 | $1.00 | ||
| Q4 24 | $0.88 | $1.12 | ||
| Q3 24 | $0.55 | $0.94 | ||
| Q2 24 | $0.53 | $1.65 | ||
| Q1 24 | $0.21 | $0.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $388.6M | $471.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.8B | $750.2M |
| 总资产 | $2.5B | $6.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $388.6M | $471.4M | ||
| Q3 25 | $616.4M | $483.3M | ||
| Q2 25 | $521.2M | $420.6M | ||
| Q1 25 | $399.8M | $413.9M | ||
| Q4 24 | $291.1M | $477.7M | ||
| Q3 24 | $396.3M | $534.9M | ||
| Q2 24 | $535.1M | $498.4M | ||
| Q1 24 | $420.8M | $465.3M |
| Q4 25 | $1.8B | $750.2M | ||
| Q3 25 | $1.7B | $758.5M | ||
| Q2 25 | $1.6B | $800.4M | ||
| Q1 25 | $1.5B | $531.5M | ||
| Q4 24 | $1.5B | $549.0M | ||
| Q3 24 | $1.3B | $551.9M | ||
| Q2 24 | $1.3B | $562.6M | ||
| Q1 24 | $1.3B | $529.9M |
| Q4 25 | $2.5B | $6.2B | ||
| Q3 25 | $2.3B | $6.2B | ||
| Q2 25 | $2.3B | $6.1B | ||
| Q1 25 | $2.1B | $5.2B | ||
| Q4 24 | $2.1B | $5.2B | ||
| Q3 24 | $2.2B | $5.2B | ||
| Q2 24 | $2.2B | $5.1B | ||
| Q1 24 | $2.1B | $5.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.1M | $164.7M |
| 自由现金流经营现金流 - 资本支出 | $170.0M | $58.5M |
| 自由现金流率自由现金流/营收 | 44.2% | 7.9% |
| 资本支出强度资本支出/营收 | 0.0% | 14.4% |
| 现金转化率经营现金流/净利润 | 3.45× | 2.21× |
| 过去12个月自由现金流最近4个季度 | $480.3M | $232.4M |
8季度趋势，按日历期对齐
| Q4 25 | $170.1M | $164.7M | ||
| Q3 25 | $101.7M | $205.2M | ||
| Q2 25 | $150.2M | $122.5M | ||
| Q1 25 | $98.8M | $98.2M | ||
| Q4 24 | $190.4M | $166.6M | ||
| Q3 24 | $81.6M | $218.1M | ||
| Q2 24 | $146.0M | $184.3M | ||
| Q1 24 | $21.1M | $7.5M |
| Q4 25 | $170.0M | $58.5M | ||
| Q3 25 | $84.4M | $135.4M | ||
| Q2 25 | $137.2M | $53.0M | ||
| Q1 25 | $88.7M | $-14.5M | ||
| Q4 24 | $180.6M | $76.0M | ||
| Q3 24 | $73.3M | $85.7M | ||
| Q2 24 | $138.9M | $78.8M | ||
| Q1 24 | $12.8M | $-72.0M |
| Q4 25 | 44.2% | 7.9% | ||
| Q3 25 | 21.4% | 22.9% | ||
| Q2 25 | 35.1% | 8.0% | ||
| Q1 25 | 28.9% | -2.5% | ||
| Q4 24 | 42.0% | 11.7% | ||
| Q3 24 | 19.4% | 15.6% | ||
| Q2 24 | 34.8% | 12.9% | ||
| Q1 24 | 3.6% | -13.6% |
| Q4 25 | 0.0% | 14.4% | ||
| Q3 25 | 4.4% | 11.8% | ||
| Q2 25 | 3.3% | 10.5% | ||
| Q1 25 | 3.3% | 19.2% | ||
| Q4 24 | 2.3% | 14.0% | ||
| Q3 24 | 2.2% | 24.1% | ||
| Q2 24 | 1.8% | 17.2% | ||
| Q1 24 | 2.4% | 15.0% |
| Q4 25 | 3.45× | 2.21× | ||
| Q3 25 | 1.23× | 5.88× | ||
| Q2 25 | 1.72× | 1.71× | ||
| Q1 25 | 4.40× | 1.56× | ||
| Q4 24 | 1.30× | 2.30× | ||
| Q3 24 | 0.88× | 3.70× | ||
| Q2 24 | 1.60× | 1.83× | ||
| Q1 24 | 0.57× | 0.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALKS
| Vivitrol | $124.1M | 32% |
| Aristada And Aristada Initio | $97.2M | 25% |
| LYBALVI | $94.1M | 24% |
| Royalty | $65.7M | 17% |
| Manufacturing Revenue | $3.3M | 1% |
RHP
| Hotel Other | $157.7M | 21% |
| Gaylord Opryland | $147.4M | 20% |
| Hotel Transient Rooms | $93.6M | 13% |
| Hotel Food And Beverage Outlets | $92.2M | 12% |
| Gaylord Palms | $88.2M | 12% |
| Jw Marriott Hill Country | $53.7M | 7% |
| Entertainment Admissions And Ticketing | $43.1M | 6% |
| Entertainment Food And Beverage | $38.1M | 5% |
| Entertainment Retail And Other | $28.3M | 4% |
| Ac Hotel | $2.4M | 0% |
